Skip to main content

Want a detailed portfolio tracker?

Jasper Therapeutics (JSPR) P/E (2021 - 2026)

Jasper Therapeutics (JSPR) P/E from Sep 24, 2021 to Jul 21, 2026. The TTM Jasper Therapeutics (JSPR) P/E is -0.29. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Jasper Therapeutics (JSPR)

YearP/EChange
2026-0.29-36.41%
2025-0.45-90.00%
2024-4.51+346.71%
2023-1.01+84.91%
2022-0.55-90.12%
2021-5.53N/A

Comparison Jasper Therapeutics (JSPR) P/E with competitors

Jasper Therapeutics (JSPR) P/E is -0.29.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.59%
NBYStablecoin Development Corp0.00-101.50%
ENLVEnlivex Ltd0.07-126.07%
FGENFibroGen Inc0.24-183.67%
CHRSCoherus Biosciences Inc0.85-395.75%
FBIOFortress Biotech Inc0.95-430.78%
ORMPOramed Pharmaceuticals Inc1.50-623.89%
AGENAgenus Inc3.01-1148.99%
INVAInnoviva Inc3.15-1199.33%
VXRTVaxart Inc3.55-1337.25%
CRMDCorMedix Inc3.63-1364.68%
CVACCureVac N.V.4.45-1649.53%
GLPGGalapagos NV4.86-1793.55%
SRPTSarepta Therapeutics Inc4.88-1801.64%
ABEOAbeona Therapeutics Inc5.39-1977.80%
ABUSArbutus Biopharma Corp5.60-2050.34%
ZVRAZevra Therapeutics Inc5.89-2151.98%
SPROSpero Therapeutics Inc6.23-2270.91%
CGENCompugen Ltd6.31-2300.71%
RIGLRigel Pharmaceuticals6.87-2495.24%
SLXNSilexion Therapeutics Corp7.30-2643.03%
OMEROmeros Corporation9.26-3327.12%
AUPHAurinia Pharmaceuticals Inc9.58-3440.82%
PLXProtalix BioTherapeutics Inc10.89-3896.04%
ACADAcadia Pharmaceuticals Inc11.73-4187.96%
TBPHTheravance Biopharma Inc12.26-4373.95%
ADMAAdma Biologics Inc12.42-4428.33%
HRMYHarmony Biosciences Holdings Inc13.82-4917.01%
SABSSAB Biotherapeutics Inc14.14-5027.16%
NAGENiagen Bioscience Inc14.82-5264.84%
INCYIncyte Corp15.82-5614.93%
REGNRegeneron Pharmaceuticals Inc15.86-5626.82%
PBYIPuma Biotechnology Inc17.32-6135.37%
CPRXCatalyst Pharmaceuticals Inc17.44-6178.45%
EXELExelixis Inc17.54-6212.86%
TGTXTG Therapeutics Inc18.97-6710.60%
MDXGMimedx Group Inc20.55-7263.56%
XOMAXOMA Royalty Corp22.87-8073.16%
ARGXArgen X SE24.30-8569.27%
CTMXCytomX Therapeutics Inc24.82-8751.60%
XOMAOXOMA Royalty Corp25.34-8934.14%
HALOHalozyme Therapeutics Inc25.62-9031.36%
XOMAPXOMA Royalty Corp25.67-9047.53%
VRTXVertex Pharmaceuticals Inc27.99-9857.79%
RPRXRoyalty Pharma plc - Class A28.69-10099.28%
SLNOSoleno Therapeutics Inc29.02-10213.54%
ASNDAscendis Pharma A/S30.09-10586.57%
LGNDLigand Pharmaceuticals Inc - Class B37.91-13314.54%
APLSApellis Pharmaceuticals Inc39.02-13701.17%
BMRNBiomarin Pharmaceutical Inc42.21-14813.29%
KRYSKrystal Biotech Inc45.34-15904.84%
ONCBeiGene Ltd69.54-24338.91%
PHARPharming Group N.V.75.03-26250.80%
TECHBio-Techne Corp101.96-35638.46%
VCELVericel Corp109.92-38414.01%
ALNYAlnylam Pharmaceuticals Inc117.96-41217.73%
GMABGenmab140.29-48999.54%
TLXTelix Pharmaceuticals Ltd162.15-56619.74%
CORTCorcept Therapeutics Inc212.86-74293.29%